James D. Peyton
Impact in
-
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
Papers in
- Oncology 16
- Cancer Treatment and Pharmacology 6
- Colorectal Cancer Treatments and Studies 3
- PARP inhibition in cancer therapy 3
- Lung Cancer Research Studies 3
-
- Lung Cancer Treatments and Mutations 11
- Gastric Cancer Management and Outcomes 5
- Lung Cancer Diagnosis and Treatment 4
- Co-authors
- John D. Hainsworth (14 shared papers)David R. Spigel (10 shared papers)Howard A. Burris (8 shared papers)Anthony A. Meluch (7 shared papers)Cassie M. Lane (7 shared papers)Mark A. Rubin (4 shared papers)Johanna C. Bendell (11 shared papers)Dianna Shipley (9 shared papers)
- Journals
- Journal of Clinical Oncology (14 papers)The Oncologist (3 papers)Journal of Thoracic Oncology (2 papers)Cancer (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
James D. Peyton
27 papers receiving 356 citations
Peers
Comparison fields: 5 of 46
- Oncology 200
- Otorhinolaryngology 29
- Pulmonary and Respiratory Medicine 145
- Cancer Research 53
- Molecular Biology 175
Countries citing papers authored by James D. Peyton
This map shows the geographic impact of James D. Peyton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Peyton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Peyton more than expected).
Fields of papers citing papers by James D. Peyton
This network shows the impact of papers produced by James D. Peyton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Peyton. The network helps show where James D. Peyton may publish in the future.
Co-authors
The 25 scholars most cited alongside James D. Peyton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 62 | |
| 2 | 2011 | 49 | |
| 3 | A phase II trial of preoperative concurrent chemotherapy/radiation therapy plus bevacizumab/erlotinib in the treatment of localized esophageal cancer. | 2012 | 42 |
| 4 | 2011 | 39 | |
| 5 | 2017 | 38 | |
| 6 | 2011 | 25 | |
| 7 | 2016 | 14 | |
| 8 | 2017 | 12 | |
| 9 | 2017 | 12 | |
| 10 | 2009 | 9 | |
| 11 | 2009 | 9 | |
| 12 | 2017 | 7 | |
| 13 | 2019 | 7 | |
| 14 | 2007 | 7 | |
| 15 | 2015 | 6 | |
| 16 | 2010 | 4 | |
| 17 | 2010 | 4 | |
| 18 | 2016 | 4 | |
| 19 | 2010 | 3 | |
| 20 | 2016 | 2 |
About James D. Peyton
James D. Peyton is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Otorhinolaryngology, having authored 27 papers that have together received 363 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Cancer Treatment and Pharmacology (6 papers), Gastric Cancer Management and Outcomes (5 papers), Lung Cancer Diagnosis and Treatment (4 papers), Esophageal Cancer Research and Treatment (4 papers), Colorectal Cancer Treatments and Studies (3 papers), PARP inhibition in cancer therapy (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Oncology (200 citations), Otorhinolaryngology (29 citations), Pulmonary and Respiratory Medicine (145 citations), Cancer Research (53 citations) and Molecular Biology (175 citations). James D. Peyton has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include John D. Hainsworth, David R. Spigel, Howard A. Burris, Anthony A. Meluch, Cassie M. Lane, Mark A. Rubin, Johanna C. Bendell, Dianna Shipley, David Waterhouse and F. Anthony Greco. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, Journal of Thoracic Oncology, Cancer and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.